Validation of the Concept of the Autoantibodies Directed Against the Neuropeptides Involved in Food Intake Regulation on the Incidental Cases of Eating Disorders
EDILS-AutoAC
2 other identifiers
interventional
211
1 country
1
Brief Summary
This study should lead to the validation of the concept of the autoAc directed against the neuropeptides involved in food intake regulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2018
CompletedFirst Posted
Study publicly available on registry
April 27, 2018
CompletedStudy Start
First participant enrolled
May 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2025
CompletedFebruary 6, 2026
February 1, 2026
7.2 years
April 4, 2018
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the rates of the autoantibodies directed against the neuropeptides (ghrelin and alpha-MSH) involved in food intake regulation among patients with eating disorders
blood samples collections
1 week
Secondary Outcomes (3)
Scale for determination factors associated with eating disorders
1 week
statute in autoantibody and behavioral characteristics of the eating disorder
1 week
Evaluation of the rate of the autoantibodies directed against bacterial peptide, ClpB among patients presenting with eating disorders
1 week
Study Arms (2)
Eating disorders patients
EXPERIMENTALfirst clinical visit in nutrition department of CHU de Rouen for eating disorders (anorexia nervosa, hyperphagia or bulimia) according to the classification DSM-V
healthy volunteers
OTHERVolunteers with negative SCOFF test (No active or history of eating disorders)
Interventions
blood samples (12ml) and stool samples (30g) collections
Eligibility Criteria
You may qualify if:
- Patients with eating disorders
- Years and older
- first clinical visit in nutrition department of CHU de Rouen for eating disorders
- anorexia nervosa, hyperphagia or bulimia according to the classification DSM-V
- social security Affiliation
- Patient who signed the MEC approved informed consent
- Volunteers
- Years to 60 Years
- body mass index ≥ 18,5 kg/m2 and ≤ 24,9 kg/m2
- negative SCOFF test
- No active and history of eating disorders
- social security Affiliation
- volunteer who signed the MEC approved informed consent
You may not qualify if:
- Patients with eating disorders
- No anorexia nervosa, hyperphagia or bulimia according to the classification DSM-V
- Adults under legal protection or under safeguard of justice or administrative decision
- Pregnancy
- Volunteers
- Active or history of eating disorder
- Adults under legal protection or under safeguard of justice or administrative decision
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre d'Investigation Clinique
Rouen, 76031, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Najate EL MACHKOURI ACHAMRAH, MD, PhD
University Hospital, Rouen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2018
First Posted
April 27, 2018
Study Start
May 24, 2018
Primary Completion
August 13, 2025
Study Completion
August 13, 2025
Last Updated
February 6, 2026
Record last verified: 2026-02